2-26458218-C-T

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 11P and 1B. PM2PP3PP5_Very_StrongBS1_Supporting

The NM_194323.3(OTOF):​c.3515G>A​(p.Arg1172Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000684 in 1,578,266 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000073 ( 1 hom. )

Consequence

OTOF
NM_194323.3 missense, splice_region

Scores

9
5
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 7.83
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 2-26458218-C-T is Pathogenic according to our data. Variant chr2-26458218-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 548986.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-26458218-C-T is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.0000729 (104/1426078) while in subpopulation EAS AF= 0.00142 (53/37346). AF 95% confidence interval is 0.00111. There are 1 homozygotes in gnomad4_exome. There are 48 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.*20G>A splice_region_variant Exon 47 of 47 ENST00000272371.7 NP_919224.1 Q9HC10-1
OTOFNM_194323.3 linkc.3515G>A p.Arg1172Gln missense_variant, splice_region_variant Exon 29 of 29 ENST00000339598.8 NP_919304.1 Q9HC10-2
OTOFNM_194248.3 linkc.*20G>A 3_prime_UTR_variant Exon 47 of 47 ENST00000272371.7 NP_919224.1 Q9HC10-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.*20G>A splice_region_variant Exon 47 of 47 1 NM_194248.3 ENSP00000272371.2 Q9HC10-1
OTOFENST00000339598.8 linkc.3515G>A p.Arg1172Gln missense_variant, splice_region_variant Exon 29 of 29 1 NM_194323.3 ENSP00000344521.3 Q9HC10-2
OTOFENST00000272371 linkc.*20G>A 3_prime_UTR_variant Exon 47 of 47 1 NM_194248.3 ENSP00000272371.2 Q9HC10-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152070
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000434
AC:
8
AN:
184120
Hom.:
0
AF XY:
0.0000506
AC XY:
5
AN XY:
98812
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000305
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000523
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000729
AC:
104
AN:
1426078
Hom.:
1
Cov.:
31
AF XY:
0.0000680
AC XY:
48
AN XY:
706214
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00142
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000448
Gnomad4 OTH exome
AF:
0.0000338
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152188
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74400
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000388
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000487
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.0000254
AC:
3

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Jan 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The OTOF gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_194323.2, and corresponds to NM_194248.2:c.*20G>A in the primary transcript. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1172 of the OTOF protein (p.Arg1172Gln). This variant is present in population databases (rs201326023, gnomAD 0.02%). This missense change has been observed in individual(s) with auditory neuropathy spectrum disorder (PMID: 26632695). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.R1939Q. ClinVar contains an entry for this variant (Variation ID: 548986). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -

Jul 04, 2023
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function and a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 35248088, 26346818, 31095577, 26632695, 24053799, 30482216, 24814232, 23562982, 27621663, 16097006, 22906306, 22575033, 14635104, 12525542, 34426522, 34424407) -

Auditory neuropathy spectrum disorder Pathogenic:1
Oct 20, 2020
Department of Otolaryngology, Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Inborn genetic diseases Pathogenic:1
Aug 06, 2024
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.*20G>A alteration is located in the 3' untranslated region (3' UTR) of the OTOF gene. This alteration consists of a G to A substitution 20 nucleotides after the last coding exon of the OTOF gene. Report as NM_001287489 c.5816G>A (p.R1939Q) - requires manual report edits Based on data from gnomAD, the A allele has an overall frequency of 0.004% (9/215492) total alleles studied. The highest observed frequency was 0.027% (4/14656) of East Asian alleles. This variant has been identified in the homozygous state and/or in conjunction with other OTOF variants in individuals with hearing loss (Matsunaga, 2012; Chang, 2015; Lee, 2021). Based on the available evidence, this alteration is classified as pathogenic. -

OTOF-related disorder Pathogenic:1
Oct 04, 2023
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The OTOF c.5816G>A variant is predicted to result in the amino acid substitution p.Arg1939Gln. This variant was reported in the homozygous and compound heterozygous states in multiple individuals with auditory neuropathy or nonsyndromic hearing loss (described as c.6141G>A, Varga. 2003. PubMed ID: 12525542; Chang. 2015. PubMed ID: 26632695; Matsunaga. 2012. PubMed ID: 22575033; Table S1, Thorpe. 2021. PubMed ID: 34424407; Mutai. 2022. PubMed ID: 35248088). This variant is reported in 0.027% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-26681086-C-T). This variant is interpreted as pathogenic. -

Autosomal recessive nonsyndromic hearing loss 9 Pathogenic:1
Feb 20, 2018
Division of Hearing and Balance Research, National Hospital Organization Tokyo Medical Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.23
CADD
Uncertain
23
DANN
Pathogenic
1.0
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.90
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Pathogenic
0.99
D;D
M_CAP
Pathogenic
0.65
D
MetaRNN
Pathogenic
0.80
D;D
MetaSVM
Uncertain
0.70
D
PROVEAN
Uncertain
-3.8
D;D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0020
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.78
MutPred
0.64
Gain of catalytic residue at R1172 (P = 0.0095);.;
MVP
0.96
ClinPred
0.44
T
GERP RS
4.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.73
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.73
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201326023; hg19: chr2-26681086; COSMIC: COSV105845159; COSMIC: COSV105845159; API